Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · IEX Real-Time Price · USD
1.690
-0.050 (-2.87%)
At close: Jul 26, 2024, 4:00 PM
1.670
-0.020 (-1.18%)
After-hours: Jul 26, 2024, 7:24 PM EDT
Entera Bio Market Cap
Entera Bio has a market cap or net worth of $60.53 million as of July 26, 2024. Its market cap has increased by 147.07% in one year.
Market Cap
60.53M
Enterprise Value
51.72M
1-Year Change
147.07%
Ranking
Category
Stock Price
$1.69
Market Cap Chart
Since June 28, 2018, Entera Bio's market cap has decreased from $71.40M to $60.53M, a decrease of -15.22%. That is a compound annual growth rate of -2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 62.30M | 260.12% |
| Dec 29, 2023 | 17.30M | -17.62% |
| Dec 30, 2022 | 21.00M | -74.07% |
| Dec 31, 2021 | 81.00M | 309.09% |
| Dec 31, 2020 | 19.80M | -23.85% |
| Dec 31, 2019 | 26.00M | -25.07% |
| Dec 31, 2018 | 34.70M | -51.40% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vor Biopharma | 64.51M |
| BioLineRx | 61.54M |
| Cryo-Cell International | 61.43M |
| Anebulo Pharmaceuticals | 60.42M |
| Estrella Immunopharma | 60.38M |
| Enzo Biochem | 60.12M |
| VolitionRx | 59.79M |
| LENSAR | 59.15M |